TY - JOUR T1 - THE CARDIOVASCULAR PHARMACOLOGY OF LIDOFLAZINE, A LONG-ACTING CORONARY VASODILATOR JF - Journal of Pharmacology and Experimental Therapeutics JO - J Pharmacol Exp Ther SP - 265 LP - 274 VL - 152 IS - 2 AU - Wolfgang K. A. Schaper AU - Raymond Xhonneux AU - Anton H. M. Jageneau AU - Paul A. J. Janssen Y1 - 1966/05/01 UR - http://jpet.aspetjournals.org/content/152/2/265.abstract N2 - A series of cardiovascular experiments with lidoflazine (R 7904) in anesthetized and unanesthetized dogs is described in detail. The results indicate that lidoflazine is a specific, orally active and very long-acting coronary vasodilating agent. It acts directly on the smooth muscles of the coronary vessels. Lidoflazine is chemically unrelated to the known coronary vasodilators. The Williams & Wilkins Comapny ER -